Visit the NCL Cancer Alliance website for details of the Your cancer pathway support guide, which offers comprehensive support for patients who are referred on a suspected cancer pathway or who have been diagnosed with cancer.

For information on two-week wait (2WW) referrals, see Suspected Cancer Two-Week Referrals (2WW). If there are issues getting an appointment within two weeks, use the Quality Alert System (QAS) form to alert NCL ICB. Direct referrals for urgent diagnostics are available as an alternative to 2WW.

Visit the Cancer Care Resources section for educational materials, DES and QOF guidance (including the 2022-23 NCL guidance pack), information about personalised cancer care, and patient-facing resources.

Visit the Screening topic page for detailed information on cancer screening.

Visit the Planned Care section for for elective care and 2WW wait times.

The Cancer Research UK (CRUK) contract hub has been updated with 2022-23 early diagnosis guidance.

Local initiatives

GPs are reminded to use the faecal immunochemical test (FIT) in both low-risk (DG30) and high-risk (NG12) cases with lower gastrointestinal (GI) symptoms.

Visit the NCL Teledermatology: Dermoscopy page for information about the NCL teledermatology service.

FIT<10 secondary care clinical pathway

Following national guidance and in collaboration with NCL providers, NCL Cancer Alliance has developed pathways within the colorectal services to move patients who have appropriate symptoms from the 2WW pathway to the NCL FIT<10 secondary care pathway. 

If a patient is referred on the colorectal 2WW pathway and they have a FIT<10 but do not have a rectal/anal mass or iron deficiency anaemia, following a clinical consultation with the patient with no alarming symptoms, they may be moved to the FIT<10 pathway for follow up.

See Downloads for the pathway.